Position in CDNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$316,891
+$50,456 QoQ
Shares Held
11,119
-21.4% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#151
of 225 holders
Holding Since
Dec 2020
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CDNA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Bridgefront Capital, LLC holds $4,900,467 across 7 Diagnostics & Research names. CDNA ranks #6 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | QGEN |
Qiagen N.V.
|
29,401 | $1,149,579 | |
| 2 | DHR |
Danaher Corp /De/
|
5,634 | $1,073,164 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
4,366 | $843,598 | |
| 4 | DGX |
Quest Diagnostics Inc
|
3,445 | $730,167 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
371 | $473,956 | |
| 6 | CDNA |
CareDx, Inc.
This page
|
11,119 | $316,891 | |
| 7 | WGS |
GeneDx Holdings Corp.
|
4,561 | $313,112 |
All Filings in CDNA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $316,891 | 11,119 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $266,435 | 14,142 | Shares | Sole | 2026-02-13 | |
| 2025-03-31 | $241,897 | 13,628 | Shares | Sole | 2025-05-15 | |
| 2023-09-30 | $77,833 | 11,119 | Shares | Sole | 2023-11-14 | |
| 2020-12-31 | $374,566 | 5,170 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||